27.07.2023 Evotec SE  DE0005664809

EQS-Adhoc: Evotec provides update on financial impact of cyber-attack


 

EQS-Ad-hoc: Evotec SE / Key word(s): Miscellaneous
Evotec provides update on financial impact of cyber-attack

27-Jul-2023 / 19:49 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Hamburg, Germany, – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) announces that it is adjusting its guidance for the fiscal year 2023.

Due to the impact of the cyber-attack, the company now expects Group revenues in the range of € 750 – 790 m (previously € 820 – 840 m); unpartnered R&D is expected in a range of € 60 – 70 m (previously € 70 – 80 m); and the adjusted EBITDA is expected to reach € 60 – 80 m (previously € 115 – 130 m).

While one-off items are affecting the outlook for 2023, optimisation measures are set to unfold their positive impact over to course of 2024 and beyond. Action Plan 2025 stays unchanged, targeting revenues of more than € 1 bn and an adjusted EBITDA of more than € 300 m.

– End of the ad hoc release –

Contact: Dr Werner Lanthaler, Chief Executive Officer, Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49.(0)40.560 81-0, [email protected]



End of Inside Information

27-Jul-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Evotec SE
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany
Phone: +49 (0)40 560 81-0
Fax: +49 (0)40 560 81-222
E-mail: [email protected]
Internet: www.evotec.com
ISIN: DE0005664809
WKN: 566480
Indices: MDAX, TecDAX
Listed: Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Nasdaq
EQS News ID: 1690425

 
End of Announcement EQS News Service

1690425  27-Jul-2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1690425&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023
Umsatzerlöse1 257,63 375,41 446,44 500,92 618,03 751,45 781,43
EBITDA1,2 57,22 95,46 123,14 51,77 101,65 102,51 66,35
EBITDA-Marge3 22,21 25,43 27,58 10,33 16,45 13,64
EBIT1,4 37,50 77,46 62,59 48,52 41,00 20,85 -47,51
EBIT-Marge5 14,56 20,63 14,02 9,69 6,63 2,78 -6,08
Jahresüberschuss1 24,00 84,06 37,23 6,25 215,51 -175,66 -83,91
Netto-Marge6 9,32 22,39 8,34 1,25 34,87 -23,38 -10,74
Cashflow1,7 10,83 156,24 42,22 44,72 122,24 203,11 36,44
Ergebnis je Aktie8 0,16 0,46 0,25 0,04 1,30 -0,99 -0,47
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Evotec
WKN Kurs in € Einschätzung Börsenwert in Mio. €
566480 8,700 Halten 1.544,70
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
16,42 35,60 0,46 75,00
KBV KCV KUV EV/EBITDA
1,38 42,39 1,98 23,61
Dividende '22 in € Dividende '23 in € Div.-Rendite '23
in %
Hauptversammlung
0,00 0,00 0,00 10.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
22.05.2024 14.08.2024 06.11.2024 24.04.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-4,51% -37,59% -59,12% -62,90%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Evotec SE  ISIN: DE0005664809 können Sie bei EQS abrufen


Biotechnologie , 566480 , EVT , XETR:EVT